UNITED STATES ~~SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549~~

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

________________

FORM 8-K

CURRENT REPORT ~~Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934~~

~~Date~~Pursuant ofto ~~Report~~Section ~~(Date~~13 ofor ~~earliest event reported~~15(d) ~~November~~ ~~10,~~of ~~2025 (November 3, 2025)~~the

Securities Exchange Act of 1934

Date of Report (Date of earliest event reported) January 30, 2026

COLGATE-PALMOLIVE COMPANY

(Exact name of registrant as specified in its charter)

Delaware	~~1-644~~	1-644	~~13-1815595~~	13-1815595
(State or Other Jurisdiction	(Commission		(IRS Employer
(State or Other Jurisdiction of Incorporation)		(Commission File Number)		(IRS Employer Identification No.)
of Incorporation)	File Number)		Identification No.)
300 Park Avenue, New York, NY			10022
(Address of Principal Executive Offices)			(Zip Code)

300 Park Avenue,

New York,

10022

(Address of Principal Executive Offices)

(Zip Code)

Registrant’s telephone number, including area code (212) 310-2000

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

¨ ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Securities 12(b) of the Act:

Title of each class	~~Trading Symbol(s)~~	~~Name of each exchange on which registered~~	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, $1.00 par value	CL	~~New York Stock Exchange~~	CL	New York Stock Exchange
0.500% Notes due 2026	~~CL26~~	~~New York Stock Exchange~~	CL26	New York Stock Exchange
0.300% Notes due 2029	~~CL29~~	~~New York Stock Exchange~~	CL29	New York Stock Exchange
1.375% Notes due 2034	~~CL34~~	~~New York Stock Exchange~~	CL34	New York Stock Exchange
0.875% Notes due 2039	CL39	New York Stock Exchange
3.250% Notes due 2035			CL35	New York Stock Exchange
0.875% Notes due 2039			CL39	New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

Emerging growth company ¨ ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨ ☐

Item 82.0102. ~~Other~~Results ~~Events~~of Operations and Financial Condition.

On ~~November 3~~January 30, ~~2025~~2026, Colgate-Palmolive Company (the “Company”) ~~executed~~issued ana ~~underwriting~~press ~~agreement~~release ~~(the~~announcing ~~“Underwriting~~its ~~Agreement”)~~earnings ~~with~~for ~~Barclays Bank PLC and Banco Bilbao Vizcaya Argentaria, S.A., as representatives of~~ the ~~several~~quarter ~~underwriters named therein (the “Underwriters”) with regard to the issuance~~ and ~~sale~~year byended ~~the~~December ~~Company of €600~~31,~~000,000~~ ~~aggregate principal amount of its 3~~2025.~~250%~~ ~~Senior~~This ~~Notes~~press ~~due~~release ~~2035 (the~~is ~~“Notes”).~~attached ~~The~~as ~~Underwriting~~Exhibit ~~Agreement~~99 ~~includes customary representations, warranties~~ and ~~covenants~~is byincorporated ~~the~~herein ~~Company. It also provides for customary indemnification~~ by ~~each of the Company and the Underwriters against certain liabilities~~reference.

The ~~public~~information ~~offering~~in Item 2.02 of ~~the~~this ~~Notes~~Current ~~was made~~Report ~~pursuant~~is tobeing ~~the~~furnished ~~Company’s~~and ~~automatic~~shall ~~shelf~~not ~~registration~~be ~~statement~~deemed on“filed” ~~Form S-3~~for ~~(File~~the ~~No. 333-275201),~~purposes ~~filed~~of ~~with~~Section 18 of the Securities ~~and~~ Exchange ~~Commission~~Act ~~(the~~of ~~“SEC”)~~1934, onas ~~October 27~~amended, ~~2023.~~or Onotherwise ~~November 5,~~subject ~~2025,~~to the ~~Company~~liabilities ~~filed~~of ~~with the~~that ~~SEC~~Section. aThe ~~Prospectus~~information ~~Supplement,~~in ~~dated~~Item ~~November 3,~~2.02 ~~2025~~of ~~(the~~this ~~“Prospectus~~Current ~~Supplement”),~~Report inshall ~~connection~~not ~~with~~be incorporated by reference into any registration statement or other document pursuant to the ~~public offering~~Securities Act of ~~the~~1933, ~~Notes~~as amended.

~~The~~Item ~~Notes~~9.01. ~~were~~Financial ~~issued~~Statements ~~on November 10, 2025 under an Indenture (“Indenture”), dated as of November 15, 1992, between the Company~~ and ~~The Bank of New York Mellon (formerly known as The Bank of New York), as trustee~~Exhibits.

The Underwriting Agreement, the Indenture and the form of the Notes are filed hereto as Exhibit 1.1, Exhibit 4.1 and Exhibit 4.2, respectively, and are incorporated herein by reference.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits. The following exhibits are filed with this document:

Exhibit Number Description


Exhibit Number			Description

99			Press release, dated January 30, 2026, issued by Colgate-Palmolive Company

104			Cover Page Interactive Data File (embedded within the Inline eXtensible Business Reporting Language (Inline XBRL) document)

1.1	Underwriting Agreement, dated November 3, 2025, by and among Colgate-Palmolive Company, Barclays Bank PLC and Banco Bilbao Vizcaya Argentaria, S.A.
4.1	Indenture, dated as of November 15, 1992, between Colgate-Palmolive Company and The Bank of New York Mellon (formerly known as The Bank of New York), as Trustee (incorporated herein by reference to Exhibit 4.1 to the Company’s Form S-3 Registration Statement and Post-Effective Amendment No. 1 filed on June 26, 1992, Registration No. 33-48840)
4.2	Form of 3.250% Senior Notes due 2035
5.1	Opinion of Hogan Lovells US LLP
23.1	Consent of Hogan Lovells US LLP (included in Exhibit 5.1)
104	Cover Page Interactive Data File (embedded within the Inline eXtensible Business Reporting Language (Inline XBRL) document)

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	COLGATE-PALMOLIVE COMPANY
Date: November 10, 2025	By:	/s/ Stanley J. Sutula III
	Name:	Stanley J. Sutula III
	Title:	Chief Financial Officer


						COLGATE-PALMOLIVE COMPANY

Date: January 30, 2026						By: /s/ Stanley J. Sutula III
						Name: Stanley J. Sutula III
						Title: Chief Financial Officer

Filing Compare · COLGATE PALMOLIVE CO